経口タンパク質・ペプチドの世界市場（～2026年）

• 英文タイトル：Global Oral Proteins and Peptides Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY08406 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は経口タンパク質・ペプチドのグローバル市場について調査・分析したレポートです。種類別（リナクロチド、カルシトニン、インスリン、オクトレオチド）市場規模、用途別（胃・消化器疾患、骨疾患、糖尿病、ホルモン性疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別経口タンパク質・ペプチドの競争状況、市場シェア ・世界の経口タンパク質・ペプチド市場：種類別市場規模 2015年-2020年（リナクロチド、カルシトニン、インスリン、オクトレオチド） ・世界の経口タンパク質・ペプチド市場：種類別市場規模予測 2021年-2026年（リナクロチド、カルシトニン、インスリン、オクトレオチド） ・世界の経口タンパク質・ペプチド市場：用途別市場規模 2015年-2020年（胃・消化器疾患、骨疾患、糖尿病、ホルモン性疾患） ・世界の経口タンパク質・ペプチド市場：用途別市場規模予測 2021年-2026年（胃・消化器疾患、骨疾患、糖尿病、ホルモン性疾患） ・北米の経口タンパク質・ペプチド市場分析：米国、カナダ ・ヨーロッパの経口タンパク質・ペプチド市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの経口タンパク質・ペプチド市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の経口タンパク質・ペプチド市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの経口タンパク質・ペプチド市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、AstraZeneca、Biocon、Generex Biotechnology、Novo Nordisk、Synergy Pharmaceuticals、Tarsa Therapeutics、Sanofi、Hoffmann-La Roche、Synthetic Biologics、Hovione、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.
The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.

Market Analysis and Insights: Global Oral Proteins and Peptides Market
The global Oral Proteins and Peptides market size is projected to reach US$ 775 million by 2026, from US$ 723.2 million in 2020, at a CAGR of 6.6%% during 2021-2026.

Global Oral Proteins and Peptides Scope and Market Size
Oral Proteins and Peptides market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Proteins and Peptides market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Oral Proteins and Peptides market is segmented into
Linaclotide
Calcitonin
Insulin
Octreotide

Segment by Application, the Oral Proteins and Peptides market is segmented into
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders

Regional and Country-level Analysis
The Oral Proteins and Peptides market is analysed and market size information is provided by regions (countries).
The key regions covered in the Oral Proteins and Peptides market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Proteins and Peptides Market Share Analysis
Oral Proteins and Peptides market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Proteins and Peptides business, the date to enter into the Oral Proteins and Peptides market, Oral Proteins and Peptides product introduction, recent developments, etc.

The major vendors covered:
Allergan
AstraZeneca
Biocon
Generex Biotechnology
Novo Nordisk
Synergy Pharmaceuticals
Tarsa Therapeutics
Sanofi
Hoffmann-La Roche
Synthetic Biologics
Hovione
Novartis

レポート目次

---

1 Study Coverage
1.1 Oral Proteins and Peptides Product Introduction
1.2 Market Segments
1.3 Key Oral Proteins and Peptides Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type
1.4.2 Linaclotide
1.4.3 Calcitonin
1.4.4 Insulin
1.4.5 Octreotide
1.5 Market by Application
1.5.1 Global Oral Proteins and Peptides Market Size Growth Rate by Application
1.5.2 Gastric & Digestive Disorders
1.5.3 Bone Diseases
1.5.4 Diabetes
1.5.5 Hormonal Disorders
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Oral Proteins and Peptides Market Size, Estimates and Forecasts
2.1.1 Global Oral Proteins and Peptides Revenue 2015-2026
2.1.2 Global Oral Proteins and Peptides Sales 2015-2026
2.2 Global Oral Proteins and Peptides, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Proteins and Peptides Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Proteins and Peptides Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Oral Proteins and Peptides Competitor Landscape by Players
3.1 Oral Proteins and Peptides Sales by Manufacturers
3.1.1 Oral Proteins and Peptides Sales by Manufacturers (2015-2020)
3.1.2 Oral Proteins and Peptides Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Proteins and Peptides Revenue by Manufacturers
3.2.1 Oral Proteins and Peptides Revenue by Manufacturers (2015-2020)
3.2.2 Oral Proteins and Peptides Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Proteins and Peptides Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Proteins and Peptides Revenue in 2019
3.2.5 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Proteins and Peptides Price by Manufacturers
3.4 Oral Proteins and Peptides Manufacturing Base Distribution, Product Types
3.4.1 Oral Proteins and Peptides Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Proteins and Peptides Product Type
3.4.3 Date of International Manufacturers Enter into Oral Proteins and Peptides Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Oral Proteins and Peptides Market Size by Type (2015-2020)
4.1.1 Global Oral Proteins and Peptides Sales by Type (2015-2020)
4.1.2 Global Oral Proteins and Peptides Revenue by Type (2015-2020)
4.1.3 Oral Proteins and Peptides Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Proteins and Peptides Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Proteins and Peptides Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Proteins and Peptides Revenue Forecast by Type (2021-2026)
4.2.3 Oral Proteins and Peptides Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Proteins and Peptides Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Oral Proteins and Peptides Market Size by Application (2015-2020)
5.1.1 Global Oral Proteins and Peptides Sales by Application (2015-2020)
5.1.2 Global Oral Proteins and Peptides Revenue by Application (2015-2020)
5.1.3 Oral Proteins and Peptides Price by Application (2015-2020)
5.2 Oral Proteins and Peptides Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Proteins and Peptides Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Proteins and Peptides Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Proteins and Peptides Price Forecast by Application (2021-2026)

6 North America
6.1 North America Oral Proteins and Peptides by Country
6.1.1 North America Oral Proteins and Peptides Sales by Country
6.1.2 North America Oral Proteins and Peptides Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Proteins and Peptides Market Facts & Figures by Type
6.3 North America Oral Proteins and Peptides Market Facts & Figures by Application

7 Europe
7.1 Europe Oral Proteins and Peptides by Country
7.1.1 Europe Oral Proteins and Peptides Sales by Country
7.1.2 Europe Oral Proteins and Peptides Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Proteins and Peptides Market Facts & Figures by Type
7.3 Europe Oral Proteins and Peptides Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Oral Proteins and Peptides by Region
8.1.1 Asia Pacific Oral Proteins and Peptides Sales by Region
8.1.2 Asia Pacific Oral Proteins and Peptides Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Type
8.3 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Application

9 Latin America
9.1 Latin America Oral Proteins and Peptides by Country
9.1.1 Latin America Oral Proteins and Peptides Sales by Country
9.1.2 Latin America Oral Proteins and Peptides Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Proteins and Peptides Market Facts & Figures by Type
9.3 Central & South America Oral Proteins and Peptides Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Oral Proteins and Peptides by Country
10.1.1 Middle East and Africa Oral Proteins and Peptides Sales by Country
10.1.2 Middle East and Africa Oral Proteins and Peptides Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Type
10.3 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Application

11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Oral Proteins and Peptides Products Offered
11.1.5 Allergan Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Oral Proteins and Peptides Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Biocon
11.3.1 Biocon Corporation Information
11.3.2 Biocon Description and Business Overview
11.3.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Biocon Oral Proteins and Peptides Products Offered
11.3.5 Biocon Related Developments
11.4 Generex Biotechnology
11.4.1 Generex Biotechnology Corporation Information
11.4.2 Generex Biotechnology Description and Business Overview
11.4.3 Generex Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Generex Biotechnology Oral Proteins and Peptides Products Offered
11.4.5 Generex Biotechnology Related Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Corporation Information
11.5.2 Novo Nordisk Description and Business Overview
11.5.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novo Nordisk Oral Proteins and Peptides Products Offered
11.5.5 Novo Nordisk Related Developments
11.6 Synergy Pharmaceuticals
11.6.1 Synergy Pharmaceuticals Corporation Information
11.6.2 Synergy Pharmaceuticals Description and Business Overview
11.6.3 Synergy Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Synergy Pharmaceuticals Oral Proteins and Peptides Products Offered
11.6.5 Synergy Pharmaceuticals Related Developments
11.7 Tarsa Therapeutics
11.7.1 Tarsa Therapeutics Corporation Information
11.7.2 Tarsa Therapeutics Description and Business Overview
11.7.3 Tarsa Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Tarsa Therapeutics Oral Proteins and Peptides Products Offered
11.7.5 Tarsa Therapeutics Related Developments
11.8 Sanofi
11.8.1 Sanofi Corporation Information
11.8.2 Sanofi Description and Business Overview
11.8.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sanofi Oral Proteins and Peptides Products Offered
11.8.5 Sanofi Related Developments
11.9 Hoffmann-La Roche
11.9.1 Hoffmann-La Roche Corporation Information
11.9.2 Hoffmann-La Roche Description and Business Overview
11.9.3 Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hoffmann-La Roche Oral Proteins and Peptides Products Offered
11.9.5 Hoffmann-La Roche Related Developments
11.10 Synthetic Biologics
11.10.1 Synthetic Biologics Corporation Information
11.10.2 Synthetic Biologics Description and Business Overview
11.10.3 Synthetic Biologics Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Synthetic Biologics Oral Proteins and Peptides Products Offered
11.10.5 Synthetic Biologics Related Developments
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Description and Business Overview
11.1.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Allergan Oral Proteins and Peptides Products Offered
11.1.5 Allergan Related Developments
11.12 Novartis
11.12.1 Novartis Corporation Information
11.12.2 Novartis Description and Business Overview
11.12.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Novartis Products Offered
11.12.5 Novartis Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Proteins and Peptides Market Estimates and Projections by Region
12.1.1 Global Oral Proteins and Peptides Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Proteins and Peptides Revenue Forecast by Regions 2021-2026
12.2 North America Oral Proteins and Peptides Market Size Forecast (2021-2026)
12.2.1 North America: Oral Proteins and Peptides Sales Forecast (2021-2026)
12.2.2 North America: Oral Proteins and Peptides Revenue Forecast (2021-2026)
12.2.3 North America: Oral Proteins and Peptides Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Proteins and Peptides Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Proteins and Peptides Sales Forecast (2021-2026)
12.3.2 Europe: Oral Proteins and Peptides Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Proteins and Peptides Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Proteins and Peptides Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Proteins and Peptides Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Proteins and Peptides Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Proteins and Peptides Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Proteins and Peptides Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Proteins and Peptides Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Proteins and Peptides Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Proteins and Peptides Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Proteins and Peptides Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Proteins and Peptides Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Proteins and Peptides Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Proteins and Peptides Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Oral Proteins and Peptides Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Proteins and Peptides Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Oral Proteins and Peptides Market Segments
Table 2. Ranking of Global Top Oral Proteins and Peptides Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Proteins and Peptides Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Linaclotide
Table 5. Major Manufacturers of Calcitonin
Table 6. Major Manufacturers of Insulin
Table 7. Major Manufacturers of Octreotide
Table 8. Global Oral Proteins and Peptides Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Oral Proteins and Peptides Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Oral Proteins and Peptides Sales by Regions 2015-2020 (K MT)
Table 11. Global Oral Proteins and Peptides Sales Market Share by Regions (2015-2020)
Table 12. Global Oral Proteins and Peptides Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Oral Proteins and Peptides Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Oral Proteins and Peptides Sales Share by Manufacturers (2015-2020)
Table 15. Global Oral Proteins and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Proteins and Peptides as of 2019)
Table 17. Oral Proteins and Peptides Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Oral Proteins and Peptides Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Oral Proteins and Peptides Price (2015-2020) (USD/MT)
Table 20. Oral Proteins and Peptides Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Oral Proteins and Peptides Product Type
Table 22. Date of International Manufacturers Enter into Oral Proteins and Peptides Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Proteins and Peptides Sales by Type (2015-2020) (K MT)
Table 25. Global Oral Proteins and Peptides Sales Share by Type (2015-2020)
Table 26. Global Oral Proteins and Peptides Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Oral Proteins and Peptides Revenue Share by Type (2015-2020)
Table 28. Oral Proteins and Peptides Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Oral Proteins and Peptides Sales by Application (2015-2020) (K MT)
Table 30. Global Oral Proteins and Peptides Sales Share by Application (2015-2020)
Table 31. North America Oral Proteins and Peptides Sales by Country (2015-2020) (K MT)
Table 32. North America Oral Proteins and Peptides Sales Market Share by Country (2015-2020)
Table 33. North America Oral Proteins and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Oral Proteins and Peptides Revenue Market Share by Country (2015-2020)
Table 35. North America Oral Proteins and Peptides Sales by Type (2015-2020) (K MT)
Table 36. North America Oral Proteins and Peptides Sales Market Share by Type (2015-2020)
Table 37. North America Oral Proteins and Peptides Sales by Application (2015-2020) (K MT)
Table 38. North America Oral Proteins and Peptides Sales Market Share by Application (2015-2020)
Table 39. Europe Oral Proteins and Peptides Sales by Country (2015-2020) (K MT)
Table 40. Europe Oral Proteins and Peptides Sales Market Share by Country (2015-2020)
Table 41. Europe Oral Proteins and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Oral Proteins and Peptides Revenue Market Share by Country (2015-2020)
Table 43. Europe Oral Proteins and Peptides Sales by Type (2015-2020) (K MT)
Table 44. Europe Oral Proteins and Peptides Sales Market Share by Type (2015-2020)
Table 45. Europe Oral Proteins and Peptides Sales by Application (2015-2020) (K MT)
Table 46. Europe Oral Proteins and Peptides Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Oral Proteins and Peptides Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Oral Proteins and Peptides Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Oral Proteins and Peptides Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Oral Proteins and Peptides Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Oral Proteins and Peptides Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Oral Proteins and Peptides Sales Market Share by Application (2015-2020)
Table 55. Latin America Oral Proteins and Peptides Sales by Country (2015-2020) (K MT)
Table 56. Latin America Oral Proteins and Peptides Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Oral Proteins and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Oral Proteins and Peptides Revenue Market Share by Country (2015-2020)
Table 59. Latin America Oral Proteins and Peptides Sales by Type (2015-2020) (K MT)
Table 60. Latin America Oral Proteins and Peptides Sales Market Share by Type (2015-2020)
Table 61. Latin America Oral Proteins and Peptides Sales by Application (2015-2020) (K MT)
Table 62. Latin America Oral Proteins and Peptides Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Oral Proteins and Peptides Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Oral Proteins and Peptides Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Oral Proteins and Peptides Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Application (2015-2020)
Table 71. Allergan Corporation Information
Table 72. Allergan Description and Major Businesses
Table 73. Allergan Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Allergan Product
Table 75. Allergan Recent Development
Table 76. AstraZeneca Corporation Information
Table 77. AstraZeneca Description and Major Businesses
Table 78. AstraZeneca Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. AstraZeneca Product
Table 80. AstraZeneca Recent Development
Table 81. Biocon Corporation Information
Table 82. Biocon Description and Major Businesses
Table 83. Biocon Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Biocon Product
Table 85. Biocon Recent Development
Table 86. Generex Biotechnology Corporation Information
Table 87. Generex Biotechnology Description and Major Businesses
Table 88. Generex Biotechnology Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Generex Biotechnology Product
Table 90. Generex Biotechnology Recent Development
Table 91. Novo Nordisk Corporation Information
Table 92. Novo Nordisk Description and Major Businesses
Table 93. Novo Nordisk Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Novo Nordisk Product
Table 95. Novo Nordisk Recent Development
Table 96. Synergy Pharmaceuticals Corporation Information
Table 97. Synergy Pharmaceuticals Description and Major Businesses
Table 98. Synergy Pharmaceuticals Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Synergy Pharmaceuticals Product
Table 100. Synergy Pharmaceuticals Recent Development
Table 101. Tarsa Therapeutics Corporation Information
Table 102. Tarsa Therapeutics Description and Major Businesses
Table 103. Tarsa Therapeutics Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Tarsa Therapeutics Product
Table 105. Tarsa Therapeutics Recent Development
Table 106. Sanofi Corporation Information
Table 107. Sanofi Description and Major Businesses
Table 108. Sanofi Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Sanofi Product
Table 110. Sanofi Recent Development
Table 111. Hoffmann-La Roche Corporation Information
Table 112. Hoffmann-La Roche Description and Major Businesses
Table 113. Hoffmann-La Roche Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Hoffmann-La Roche Product
Table 115. Hoffmann-La Roche Recent Development
Table 116. Synthetic Biologics Corporation Information
Table 117. Synthetic Biologics Description and Major Businesses
Table 118. Synthetic Biologics Oral Proteins and Peptides Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Synthetic Biologics Product
Table 120. Synthetic Biologics Recent Development
Table 121. Hovione Corporation Information
Table 122. Hovione Description and Major Businesses
Table 123. Hovione Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Hovione Product
Table 125. Hovione Recent Development
Table 126. Novartis Corporation Information
Table 127. Novartis Description and Major Businesses
Table 128. Novartis Oral Proteins and Peptides Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Novartis Product
Table 130. Novartis Recent Development
Table 131. Global Oral Proteins and Peptides Sales Forecast by Regions (2021-2026) (K MT)
Table 132. Global Oral Proteins and Peptides Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Oral Proteins and Peptides Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Oral Proteins and Peptides Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Oral Proteins and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 136. North America: Oral Proteins and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Oral Proteins and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 138. Europe: Oral Proteins and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Oral Proteins and Peptides Sales Forecast by Region (2021-2026) (K MT)
Table 140. Asia Pacific: Oral Proteins and Peptides Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Oral Proteins and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 142. Latin America: Oral Proteins and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Oral Proteins and Peptides Sales Forecast by Country (2021-2026) (K MT)
Table 144. Middle East and Africa: Oral Proteins and Peptides Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Oral Proteins and Peptides Players
Table 149. Oral Proteins and Peptides Customers List
Table 150. Oral Proteins and Peptides Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Proteins and Peptides Product Picture
Figure 2. Global Oral Proteins and Peptides Sales Market Share by Type in 2020 & 2026
Figure 3. Linaclotide Product Picture
Figure 4. Calcitonin Product Picture
Figure 5. Insulin Product Picture
Figure 6. Octreotide Product Picture
Figure 7. Global Oral Proteins and Peptides Sales Market Share by Application in 2020 & 2026
Figure 8. Gastric & Digestive Disorders
Figure 9. Bone Diseases
Figure 10. Diabetes
Figure 11. Hormonal Disorders
Figure 12. Oral Proteins and Peptides Report Years Considered
Figure 13. Global Oral Proteins and Peptides Market Size 2015-2026 (US$ Million)
Figure 14. Global Oral Proteins and Peptides Sales 2015-2026 (K MT)
Figure 15. Global Oral Proteins and Peptides Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Oral Proteins and Peptides Sales Market Share by Region (2015-2020)
Figure 17. Global Oral Proteins and Peptides Sales Market Share by Region in 2019
Figure 18. Global Oral Proteins and Peptides Revenue Market Share by Region (2015-2020)
Figure 19. Global Oral Proteins and Peptides Revenue Market Share by Region in 2019
Figure 20. Global Oral Proteins and Peptides Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Oral Proteins and Peptides Revenue in 2019
Figure 22. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Oral Proteins and Peptides Sales Market Share by Type (2015-2020)
Figure 24. Global Oral Proteins and Peptides Sales Market Share by Type in 2019
Figure 25. Global Oral Proteins and Peptides Revenue Market Share by Type (2015-2020)
Figure 26. Global Oral Proteins and Peptides Revenue Market Share by Type in 2019
Figure 27. Global Oral Proteins and Peptides Market Share by Price Range (2015-2020)
Figure 28. Global Oral Proteins and Peptides Sales Market Share by Application (2015-2020)
Figure 29. Global Oral Proteins and Peptides Sales Market Share by Application in 2019
Figure 30. Global Oral Proteins and Peptides Revenue Market Share by Application (2015-2020)
Figure 31. Global Oral Proteins and Peptides Revenue Market Share by Application in 2019
Figure 32. North America Oral Proteins and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 33. North America Oral Proteins and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Oral Proteins and Peptides Sales Market Share by Country in 2019
Figure 35. North America Oral Proteins and Peptides Revenue Market Share by Country in 2019
Figure 36. U.S. Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 37. U.S. Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 39. Canada Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Oral Proteins and Peptides Market Share by Type in 2019
Figure 41. North America Oral Proteins and Peptides Market Share by Application in 2019
Figure 42. Europe Oral Proteins and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 43. Europe Oral Proteins and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Oral Proteins and Peptides Sales Market Share by Country in 2019
Figure 45. Europe Oral Proteins and Peptides Revenue Market Share by Country in 2019
Figure 46. Germany Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 47. Germany Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 49. France Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 51. U.K. Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 53. Italy Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 55. Russia Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Oral Proteins and Peptides Market Share by Type in 2019
Figure 57. Europe Oral Proteins and Peptides Market Share by Application in 2019
Figure 58. Asia Pacific Oral Proteins and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 59. Asia Pacific Oral Proteins and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region in 2019
Figure 61. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region in 2019
Figure 62. China Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 63. China Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 65. Japan Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 67. South Korea Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 69. India Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 71. Australia Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 73. Taiwan Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 75. Indonesia Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 77. Thailand Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 79. Malaysia Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 81. Philippines Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 83. Vietnam Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Oral Proteins and Peptides Market Share by Type in 2019
Figure 85. Asia Pacific Oral Proteins and Peptides Market Share by Application in 2019
Figure 86. Latin America Oral Proteins and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 87. Latin America Oral Proteins and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Oral Proteins and Peptides Sales Market Share by Country in 2019
Figure 89. Latin America Oral Proteins and Peptides Revenue Market Share by Country in 2019
Figure 90. Mexico Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 91. Mexico Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 93. Brazil Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 95. Argentina Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Oral Proteins and Peptides Market Share by Type in 2019
Figure 97. Latin America Oral Proteins and Peptides Market Share by Application in 2019
Figure 98. Middle East and Africa Oral Proteins and Peptides Sales Growth Rate 2015-2020 (K MT)
Figure 99. Middle East and Africa Oral Proteins and Peptides Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country in 2019
Figure 102. Turkey Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 103. Turkey Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 105. Saudi Arabia Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Oral Proteins and Peptides Sales Growth Rate (2015-2020) (K MT)
Figure 107. U.A.E Oral Proteins and Peptides Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Oral Proteins and Peptides Market Share by Type in 2019
Figure 109. Middle East and Africa Oral Proteins and Peptides Market Share by Application in 2019
Figure 110. North America Oral Proteins and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. North America Oral Proteins and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Oral Proteins and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Europe Oral Proteins and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Oral Proteins and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Asia Pacific Oral Proteins and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Oral Proteins and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Latin America Oral Proteins and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Oral Proteins and Peptides Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 119. Middle East and Africa Oral Proteins and Peptides Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed

---